Martin D. Madaus, Director at REPLIGEN CORP (RGEN), bought 1,511 shares at $159.19 ($240K) on 2023-05-05, disclosed to the SEC on 2023-05-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $186.22 | 11 | $2K | 0.9% |
| 2 | $161.15 | 500 | $81K | 33.5% |
| 3 | $159.19 | 500 | $80K | 33.1% |
| 4 | $156.18 | 500 | $78K | 32.5% |
| Total | $159.04 avg | 1,511 | $240K | 100% |
| Filing → |
| AZTA | BUY | 2024-11-19 | $403K | — | Filing → |
| RGEN | BUY | 2024-06-14 | $316K | — | Filing → |
| QTRX | BUY | 2022-08-10 | $1.5M | — | Filing → |